Psychedelics firms are staking their claim in the biotech industry. The post Psychedelic Firms to Present at JP Morgan Healthcare Conference This Week...
MAPS Public Benefit Corporation (“MAPS PBC”), a company dedicated to transforming mental healthcare, announced an oversubscribed Series A financing....
Sexual abuse during psychedelic treatments continues to be a major issue within the industry. Sexual misconduct does happen during psychedelic treatments,...
–Recently announced positive Phase 2 topline data in Major Depressive Disorder (“MDD”) with 79% of patients in remission from depression after two...
If you’re interested in becoming a psychedelic therapist, deciding on how to train as one can be a bit of a minefield. There are now many...
Substances being produced at a more rapid rate this year will include psilocybin, DMT and delta-9 THC The post DEA sharply increases quantities of psychedelics,...
The study also found a "statistically significant reduction" in suicidal ideation from participants. The post New Ibogaine Study for Vets Finds Positive...
The move marks a departure from the firm's previous reliance on philanthropic funding. The post Lykos Therapeutics Secures $100M in Series A Funding,...
Beckley Psytech focuses on short duration psychedelic drug treatments. The post Atai Makes $50 Million Investment Into Beckley Psytech appeared first on...
“Neuroplasticity and Psychedelics” is a live webinar event brought to you by Wondermed and Neuly. It will be held on Monday, January 15th at 3pm ET....